Oxaliplatin infusion-related venous pain: prevention by simultaneous intravenous fluids.

Stefan G van RavensteijnBritt van MerrienboerStefan van AstenJohannes PruijtMirrian HilbinkJolien Tol

Published in: BMJ supportive & palliative care (2020)

Concurrent infusion of 800 mL glucose 5% with peripheral venous administration of oxaliplatin significantly reduces the incidence of infusion-related pain in gastrointestinal cancer patients and is highly feasible and affordable in everyday clinical practice.

Keyphrases

chronic pain
low dose
clinical practice
pain management
neuropathic pain
squamous cell carcinoma
locally advanced
blood pressure
spinal cord injury
rectal cancer
weight loss
drug induced